This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Clorox (CLX) Beats Q3 Earnings & Sales Estimates, Ups View
by Zacks Equity Research
Clorox's (CLX) Q3 results reflect gains from a solid product pipeline, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
Take the Zacks Approach to Beat the Market: Microsoft, Novo Nordisk, General Mills in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Church & Dwight (CHD) Q1 Earnings Top Estimates, Increase Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter top and bottom lines increase year over year, driven by the strong consumer demand for its products.
Here's What Key Metrics Tell Us About Church & Dwight (CHD) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for Church & Dwight (CHD) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Church & Dwight (CHD) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 11.84% and 5.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Church & Dwight (CHD) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2023 results are likely to reflect profit from strong consumer demand. It is likely to reflect benefits from strong pricing action incurred to counter inflation.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 3.79% and 4.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Church & Dwight (CHD) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Take the Zacks Approach to Beat the Market: NVIDIA, Novo Nordisk, Magenta in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Will Strong Brand Portfolio Aid Church & Dwight's (CHD) Growth?
by Zacks Equity Research
Church & Dwight's (CHD) pricing efforts, buyouts and favorable demand act as upsides against macroeconomic headwinds.
Zacks Industry Outlook Highlights The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox
by Zacks Equity Research
The Procter & Gamble, Colgate-Palmolive, Henkel AG, Church & Dwight and The Clorox are part of the Zacks Industry Outlook article.
5 Soaps & Cleaning Materials Stocks to Watch as Industry Catches Pace
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on robust demand, pricing initiatives, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, HENKY, CHD and CLX seem well-poised.
Beat the Market the Zacks Way: Kazia Therapeutics, Uber, Medtronic in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Church & Dwight (CHD) Q4 Earnings Top Estimates, Decline Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) fourth-quarter 2022 results reflect improved sales and a decline in earnings per share. Soft consumption in discretionary categories is a downside.
Church & Dwight (CHD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 3.33% and 2.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 50.77% and 2.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Church & Dwight (CHD) in Q4 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) Q4 earnings are likely to reflect gross margin contraction due to rising inflation. Nevertheless, it is resorting to incremental pricing actions to counter rising costs.
Colgate-Palmolive (CL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 1.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.
Church & Dwight (CHD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Church & Dwight (CHD) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Growth Efforts Aid Church & Dwight (CHD) Amid Inflation?
by Zacks Equity Research
Despite inflation concerns, Church & Dwight's (CHD) pricing efforts, buyouts and favorable demand act as upsides.